Zobrazeno 1 - 10
of 173
pro vyhledávání: '"J, Larribaud"'
Publikováno v:
Therapie. 34(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::973926b4da73bd0116b1f6aeab4f3bd8
https://pubmed.ncbi.nlm.nih.gov/531779
https://pubmed.ncbi.nlm.nih.gov/531779
Autor:
J. M. Segrestaa, C. Caulin, J. F. Thiercelin, J. Larribaud, D. Houlbert, Dahan R, P. Herman, J. P. Sauvanet
Publikováno v:
European journal of clinical pharmacology. 26(4)
The effect of the calcium antagonist, diltiazem, on glycoregulation was investigated in 12 healthy volunteers using a standard glucose tolerance test. No significant change was observed in plasma glucose, insulin or glucagon levels after oral treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fe720ab37961f81c074b1a8ac5a44d9
https://pubmed.ncbi.nlm.nih.gov/6376146
https://pubmed.ncbi.nlm.nih.gov/6376146
Autor:
J P, Anglade, J P, Coquelin, C, Marhic, J, Larribaud, M, Broquaire, P R, Guinebault, P L, Morselli
Publikováno v:
Therapie. 36(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::07f646c16d7c21906874d543eec62dd6
https://pubmed.ncbi.nlm.nih.gov/7323997
https://pubmed.ncbi.nlm.nih.gov/7323997
Publikováno v:
Acta cardiologica. 35(1)
Dilitazem, a coronary vasodilating agent, after oral administration of four different doses, was well and rapidly absorbed. The pharmacokinetics of the drug followed a two-compartment model, with a rapid distribution and an elimination with a half-li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::33a4c1f168f471093e44c4811fdec2a9
https://pubmed.ncbi.nlm.nih.gov/6967667
https://pubmed.ncbi.nlm.nih.gov/6967667
Autor:
Y, Buisson, J, Larribaud
Publikováno v:
Therapie. 44(2)
Effect of nifuroxazide on fecal flora was studied in 12 healthy volunteers receiving, in hazardous order and double-blind procedure, three six-days courses of treatment separated by eight-days spaces of time: the conventional dosage of 400 mg twice a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::83beb25fe8b6c13f22e9ef6384c3fc3e
https://pubmed.ncbi.nlm.nih.gov/2756516
https://pubmed.ncbi.nlm.nih.gov/2756516
Autor:
G, Bianchetti, C, Blatrix, R, Gomeni, J R, Kilborn, J, Larribaud, P W, Lücker, J J, Thebault, S, Trocherie, P L, Morselli
Publikováno v:
Arzneimittel-Forschung. 30(11)
(+/-)-1-(Isopropylamino)-3-[p-(2-cyclopropyl-methoxyethyl)-phenoxy]-2-propanol HCl (betaxolol, SL 75212) was given to groups of healthy volunteers, 10 mg daily for 7 days followed by 20 mg daily 7 days in one group, and increasing daily doses up to 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dbe5b401e3dbe9a521be53b4796bd01e
https://pubmed.ncbi.nlm.nih.gov/6109538
https://pubmed.ncbi.nlm.nih.gov/6109538
Autor:
P, Vinceneux, M, Canal, Y, Domart, A, Roux, B, Cascio, B, Orofiamma, J, Larribaud, B, Flouvat, C, Carbon
Publikováno v:
International journal of clinical pharmacology, therapy, and toxicology. 24(3)
Pharmacokinetic and pharmacodynamic interactions between nifedipine and two beta-blocking agents were investigated. Eighty mg propranolol twice daily, and 20 mg betaxolol once daily, were randomly administered orally to six young healthy male volunte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1de4ee9d6c3f376129630d572e3ca4d6
https://pubmed.ncbi.nlm.nih.gov/2870990
https://pubmed.ncbi.nlm.nih.gov/2870990
Autor:
J F, Thiercelin, G, Bianchetti, J, Larribaud, J, Ganansia, C, Deves, S, Trocherie, C, Abriol, P L, Morselli
Publikováno v:
World review of nutrition and dietetics. 43
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::20364b994d0a1235a5a70cd00c53643a
https://pubmed.ncbi.nlm.nih.gov/6147938
https://pubmed.ncbi.nlm.nih.gov/6147938